KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Rigel Pharmaceuticals (RIGL) Debt Ratio (2019 - 2025)

Historic Debt Ratio for Rigel Pharmaceuticals (RIGL) over the last 7 years, with Q3 2025 value amounting to 0.25.

  • Rigel Pharmaceuticals' Debt Ratio fell 4254.65% to 0.25 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.25, marking a year-over-year decrease of 4254.65%. This contributed to the annual value of 0.36 for FY2024, which is 2841.73% down from last year.
  • As of Q3 2025, Rigel Pharmaceuticals' Debt Ratio stood at 0.25, which was down 4254.65% from 0.29 recorded in Q2 2025.
  • In the past 5 years, Rigel Pharmaceuticals' Debt Ratio ranged from a high of 0.52 in Q3 2023 and a low of 0.09 during Q1 2021
  • For the 5-year period, Rigel Pharmaceuticals' Debt Ratio averaged around 0.32, with its median value being 0.34 (2025).
  • Its Debt Ratio has fluctuated over the past 5 years, first surged by 22018.79% in 2022, then crashed by 4254.65% in 2025.
  • Quarter analysis of 5 years shows Rigel Pharmaceuticals' Debt Ratio stood at 0.12 in 2021, then surged by 146.85% to 0.29 in 2022, then surged by 73.07% to 0.51 in 2023, then fell by 28.42% to 0.36 in 2024, then plummeted by 32.33% to 0.25 in 2025.
  • Its Debt Ratio was 0.25 in Q3 2025, compared to 0.29 in Q2 2025 and 0.34 in Q1 2025.